-       Report 
   - April 2025
    -  185 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                  -       Report 
   - December 2024
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
      €4359EUR$4,850USD£3,823GBP 
                      Cefpodoxime is an antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are used to treat a wide range of infections caused by bacteria. Cefpodoxime is used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to treat certain sexually transmitted diseases. Cefpodoxime is generally well tolerated and has a low risk of side effects.
Cefpodoxime is available in both oral and injectable    forms. It is available as a generic drug and is also sold under the brand names Vantin and Simplicef. It is available in a variety of strengths and formulations, including tablets, capsules, and suspensions.
The cefpodoxime market is highly competitive, with a number of companies offering products in the market. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less   Read more